Earnings in 4d
Genenta Science (ADR)
Develops tumor-targeted gene therapy and staged Italian defense and aerospace investments.
$1.00
After-hours close−0.01 (−0.99%)
At close$1.01(+1.95%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 5.41%1.04M sharesInsiders 12.16%2.33M sharesOther 82.43%15.78M shares
Shares outstanding 19.15M · Float 13.87M · 72.4% free float
Institutions13F, as of Mar 31, 2026
11 holders · 1.04M shares · 3 new positions · 5 increased · 2 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Eurizon Capital SGR S.P.A. | 360.0K | 1.88% | 0 | May 8, 2026 |
| Allianz SE | 234.1K | 1.22% | 0 | May 11, 2026 |
| Cartesian Growth Corp | 200.3K | 1.05% | 0 | May 7, 2026 |
| Smartharvest Portfolios, LLC | 134.4K | 0.70% | +116.7K | Apr 21, 2026 |
| Independent Advisor Alliance | 37.0K | 0.19% | +37.0Knew | May 12, 2026 |
| XTX Topco Ltd | 24.5K | 0.13% | +24.5Knew | May 15, 2026 |
| Morgan Stanley | 15.4K | 0.08% | −30.5K | May 15, 2026 |
| Gamma Investing LLC | 14.3K | 0.07% | +11.5K | Apr 6, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Fidim S.p.A.incl. Vittorio Avogadro di Collobiano, Gaudenzio Roveda +8 more | 23.00% | 5.43M | 13D | May 5, 2026 ↗ |
| Pierluigi Paracchi | 9.80% | 2.30M | 13G | Jan 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Paracchi Pierluigi | director, 10 percent owner, officer: Chief Executive Officer | 2.28M | 11.88% | Mar 18, 2026 |
| Miguel Maria Mutti | director | 33.3K | 0.17% | Mar 18, 2026 |
| Richard B. Slansky | officer: Chief Financial Officer | 19.9K | 0.10% | Mar 18, 2026 |
1 ten-percent owner holds 184.9K shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (20.0K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.